Liquid chromatography/mass spectrometry for therapeutic drug monitoring of immunosuppressants
- 15 September 2003
- journal article
- review article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 492 (1-2) , 133-145
- https://doi.org/10.1016/s0003-2670(03)00410-0
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- High‐throughput semi‐automated 96‐well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole bloodRapid Communications in Mass Spectrometry, 2001
- Current opinions on therapeutic drug monitoring of immunosuppressive drugsClinical Therapeutics, 1999
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)Therapeutic Drug Monitoring, 1995
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by ErythrocytesJournal of Pharmacy and Pharmacology, 1994
- Recent Advances in High-Performance Liquid Chromatography/Mass Spectrometry and High-Performance Liquid Chromatography/Tandem Mass SpectrometryTherapeutic Drug Monitoring, 1993
- Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activityBiochemistry, 1992
- PRODUCTION OF SYNERGISTIC BUT NONIDENTICAL MECHANISMS OF IMMUNOSUPPRESSION BY RAPAMYCIN AND CYCLOSPORINETransplantation, 1991